A Clinically Applicable Conversion Formula between NT-proBNP and BNP in Light-Chain Amyloidosis

JACC. CardioOncology · Published 2026-07-01 · DOI 10.1016/j.jaccao.2026.06.001

Free full text

Authors (10)

Eli Muchtar, Allan S. Jaffe, Andrew Staron, Vaishali Sanchorawala, Heather Landau, Oren Pasvolsky, Rajshekhar Chakraborty, Suzanne Lentzsch, Morie A. Gertz, Angela Dispenzieri

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Muchtar, E., Jaffe, A., Staron, A., et al. (2026). A Clinically Applicable Conversion Formula between NT-proBNP and BNP in Light-Chain Amyloidosis. JACC. CardioOncology. https://doi.org/10.1016/j.jaccao.2026.06.001

Related articles

• CRISPR/Cas9 Screens Implicate RARA and SPNS1 in Doxorubicin Cardiotoxicity · JACC. CardioOncology · 2026 · Same journal
• Sacubitril/Valsartan in Anthracycline-Treated Patients · JACC. CardioOncology · 2026 · Same journal
• Major Adverse Cardiovascular Events and Cardiac Dysfunction in Patients With Acute Leukemia · JACC. CardioOncology · 2026 · Same journal
• Screened But Unproven · JACC. CardioOncology · 2026 · Same journal
• Treatment and Outcomes in Myocardial Infarction and Cancer—A German Real-Life Analysis · JACC. CardioOncology · 2026 · Same journal
• Sotatercept for the Treatment of Myeloproliferative Neoplasm–Associated Group 5 Pulmonary Hypertension · JACC. CardioOncology · 2026 · Same journal
• The Promise and Pitfalls of TTR Stabilization Assays in ATTR-CM · JACC. CardioOncology · 2026 · Same journal
• Elevated Plasma IL-18 Levels During Chemotherapy Treatment for Breast Cancer, Exercise Capacity, and Physical Activity · JACC. CardioOncology · 2026 · Same journal
• Proactive Surveillance for ICI Cardiotoxicity · JACC. CardioOncology · 2026 · Same journal
• Reply · JACC. CardioOncology · 2026 · Same journal